Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 14,570.66 848.51 210.21 -203.57 35.23 0.00 20.9654 -0.39 -1.0782 -24.5246 -0.09 -0.09 6.7223 - -
Maximum - - - - - - 475,026.00 65,349.00 25,407.00 99,050.00 5,305.00 0.01 1,336.3467 6.70 3.0051 85.3485 0.38 8.35 37.1953 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -101.7758 -1,444.7800 -1.56 -12.64 0.0007 - -
Nuvalent, Inc. NUVL 95.42 1.33 1.41% 251 vs. 514 6,660.00 0.00 -44.00 -36.00 -330.00 -0.6900 -27.7942 0.0000 0.0000 0.0000 -0.0659 -0.0628 20.6970 69.00
Structure Therapeutics Inc. GPCR 38.02 -0.33 -0.86% 407 vs. 676 2,174.00 0.00 -26.00 -34.00 -232.00 -0.5600 -18.2892 0.0000 0.0000 0.0000 -0.0606 -0.0569 18.5046 57.00
Akero Therapeutics, Inc. AKRO 34.45 -0.42 -1.20% 791 vs. 505 2,391.00 0.00 -53.00 -35.00 -627.00 -0.9000 -6.6902 0.0000 0.0000 0.0000 -0.0630 -0.0585 29.8643 69.00
Arcellx, Inc. ACLX 103.06 3.90 3.93% 836 vs. 520 5,540.00 39.00 -7.00 -38.00 -396.00 -0.1400 -122.7330 0.0000 0.9790 -0.1834 -0.0145 -0.0092 5.3496 53.00
MoonLake Immunotherapeutics MLTX 51.78 1.11 2.19% 190 vs. 303 3,256.00 0.00 -13.00 -15.00 -130.00 -0.2200 -55.6575 0.0000 0.0000 0.0000 -0.0252 -0.0242 61.5621 62.00
Cerevel Therapeutics Holdings, Inc. CERE 44.96 0.33 0.74% 15,033 vs. 2,056 8,191.00 0.00 -131.00 -119.00 -1,532.00 -0.7300 -14.5661 0.0000 0.0000 0.0000 -0.2337 -0.1170 10.1215 182.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for MLTX and its peers to uncover potential buy and sell opportunities.